CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Components of Revenue:
Revenue, net	$ 45,309	$ 65,896
Costs and Expenses:
Cost of revenues	49,031	42,373
Selling, general and administrative expenses	27,011	20,785
Impairment charges	101,533	0
Product development and research expenses	7,674	10,758
Total costs and expenses	185,249	73,916
Operating loss	(139,940)	(8,020)
Other Income (Expense):
Other income	3,349	0
Foreign currency exchange gain/(loss)	4,961	(1,523)
Debt partial extinguishment of 2019 Notes	0	(185)
Interest and other expense, net	(28,824)	(21,154)
Gain/(loss) on debt restructuring	51,858	(920)
Inducement loss	(9,183)	0
Change in the fair value of derivative liabilities	(2,305)	6,769
Loss before income tax expense	(120,084)	(25,033)
Income tax expense	1,938	91
Net loss attributable to common stockholders	$ (122,022)	$ (25,124)
Basic and diluted loss per share (in dollars per share)	$ (14.67)	$ (4.67)
Weighted average shares of common stock outstanding:
Basic and diluted (in shares)	8,319,388	5,383,914